Of note, only 18.8% of the ASCL1-expressing (GFP+) cells were labeled by Ki67, while 81.2% of the Ki67-positive cells were detected in the non-infected (GFP-) glioma cells (Supplementary Figure S4A,B). Here, MKI67 is linked to central nervous system cancer.